Skip to content

Author

R. Hasselbalch

We have 8 of 114 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cardiac troponin elevations and risk of major adverse cardiovascular events in five non-cardiac diseases

Cardiac troponins (cTn) are biomarkers of myocardial injury and a cornerstone in the diagnosis of acute coronary syndrome (ACS); However, cTn elevations are frequently observed in non-cardiac diseases and have been associated with adverse outcomes. The prognostic implications and differences between high-sensitiv...

S. Knudsen, R. Hasselbalch, N. Strandkjaer et al. · 0 citations
Open access Oct 2026

Cumulative smoking exposure and prevalence of silent atherosclerosis in the REACT study

Smoking is a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD), yet the dose–response relationship between cumulative smoking exposure and silent atherosclerosis remains poorly characterised. We aimed to assess the association between lifetime smoking exposure and imaging-defi...

A. Ahmad, J. Kunkel, M. Valentin et al. · 0 citations
Open access Oct 2026

Depression and anxiety in a primary prevention study: a preliminary analysis from the REACT study

Depression and anxiety are associated with adverse cardiovascular outcomes and have been identified as priority targets for assessment and intervention in cardiovascular care (1). Despite this, systematic mental health assessment is not routinely integrated into cardiovascular screening programmes. The aim of thi...

L. Pehrson, J. Kunkel, M. Kragh et al. · 0 citations
Open access Oct 2026

Impact of atherogenic lipoproteins and inflammatory markers on silent atherosclerosis

Atherogenic lipoproteins are causal drivers of atherosclerotic cardiovascular disease (ASCVD). Emerging data has implicated inflammation as a key contributor to ASCVD. However, in adults without established ASCVD, it remains uncertain whether atherogenic lipid-plaque associations persists after accounting for mea...

N. Sandau, R. Hasselbalch, K. Iversen et al. · 0 citations
Open access Sep 2026

The Half-Life of Long Forms of Cardiac Troponin T.

BACKGROUND Long forms of cardiac troponin T (cTnT) are promising markers that may differentiate myocardial infarction from other causes of acute and chronic myocardial injury. However, to understand the clinical utility of long cTnT, knowledge of the half-life (T½) is key. By using auto-transfusion in humans we determi...

R. Hasselbalch, S. Salonen, J. Kristensen et al. · 0 citations
Open access Aug 2026

Serial high-sensitivity troponin-T and risk of heart failure in individuals with suspected acute coronary syndrome.

AIMS To investigate the association between serial high-sensitivity cardiac troponin-T (hs-TnT) concentrations and subsequent heart failure in individuals presenting with suspected acute coronary syndrome (ACS). METHODS AND RESULTS Utilizing Danish nationwide registries, we identified individuals without known heart...

Philip Ahle Erichsen, Majid Afzal, Christina Byrne et al. · 1 citation
Sep 2026

Electrocardiogram Abnormalities and the Risk of Out-of-Hospital Cardiac Arrest: A Nationwide Cohort Study.

BACKGROUND Electrocardiograms (ECGs) potentially represent strong risk predictors, but their role in risk stratification for out-of-hospital cardiac arrest (OHCA) is unclear. OBJECTIVE This study aimed to assess 5-year OHCA risk for different ECG abnormalities. METHODS Data on patients and their respective first-re...

M. Hindborg, M. P. Andersen, K. K. Sørensen et al. · 0 citations
Aug 2026

Prevalence of Silent Atherosclerosis across Adult Life.

This study of silent atherosclerosis showed that the disease was detectable in early adulthood, with age- and sex-associated increases in prevalence across arterial territories and marked increases in plaque volume.

H. Bundgaard, I. García-Lunar, K. F. Kofoed et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.